In AD models, supplementation with Sargassum fusiforme extracts in APP/PS1 transgenic mice has been reported to reduce amyloid-β deposition, attenuate tau hyperphosphorylation, and improve performance in behavioral assays [62]. Here, MAPT is linked to Alzheimer disease.